Research into inherited retinal diseases (IRD) is often regarded as the cutting-edge of ophthalmological, and indeed medical, research worldwide. 1 While most clinical trials investigating IRDs have been conducted internationally to date, these are expected to expand in Australia over the coming years and will therefore offer more people affected by IRDs the opportunity to become involved. Given the complexity of the research however, it can be difficult for patients to fully understand what these projects involve.